Δευτέρα 23 Σεπτεμβρίου 2019

Medications and the larynx
Purpose of review The larynx is a complex organ that houses some of the most intricate structures of the human body. Owing to its delicate nature, the larynx is affected by different medications to varying degrees. Many of these effects manifest in subjective complaints in one's voice or swallow. This review article invokes the present available literature to describe the effects different medical agents have on the functionality of the laryngeal structures. Recent findings Multiple available...
Current Opinion in Otolaryngology & Head and Neck Surgery - Published Ahead-of-Print
4h
Gastric inlet patches: symptomatic or silent?
Purpose of review The purpose of this review is to assess recent literature on the clinical relevance of the gastric inlet patch with particular focus on endoscopic diagnosis and treatment, the relationship of the inlet patch to laryngopharyngeal reflux disease and the association of proximal esophageal adenocarcinoma with inlet patch. Recent findings Recent studies suggest endoscopic diagnosis of inlet patch increases with endoscopist awareness (up to 10-fold) and when using enhanced imaging...
Current Opinion in Otolaryngology & Head and Neck Surgery - Published Ahead-of-Print
4h
Safety of in-office laryngology procedures
Purpose of review A wide range of diagnostic and therapeutic laryngology procedures are currently performed in an office setting. In-office laryngology procedures (IOLP) are increasingly seen as standard-of-care, and while generally considered safe, high-quality evidence supporting the latter statement is lacking. This review aims to summarize recent literature regarding the safety of IOLP. Recent findings There is a paucity of guidelines and standardized protocols for IOLP. To date, there...
Current Opinion in Otolaryngology & Head and Neck Surgery - Published Ahead-of-Print
4h
The correlation of BER protein, IRF3 with CD8+ T cell and their prognostic significance in upper tract urothelial carcinoma
OncoTargets and Therapy
4h
MAGEC2 Correlates With Unfavorable Prognosis And Promotes Tumor Development In HCC Via Epithelial-Mesenchymal Transition
OncoTargets and Therapy
4h
Synergistic effect of a retinoid X receptor-selective ligand bexarotene and docetaxel in prostate cancer
OncoTargets and Therapy
6h
LINC00565 promotes proliferation and inhibits apoptosis of gastric cancer by targeting miR-665/AKT3 axis
OncoTargets and Therapy
6h
Targeted Therapy For RET-Rearranged Non-Small Cell Lung Cancer: Clinical Development And Future Directions
OncoTargets and Therapy
6h
The Effects of Age and Fasting Models on Blood Pressure, Insulin/Glucose Profile, and Expression of Longevity Proteins in Male Rats
Rejuvenation Research, Ahead of Print.
Rejuvenation Research
4h
Natural Compounds as a Strategy to Optimize “In Vitro” Expansion of Stem Cells
Rejuvenation Research, Ahead of Print.
Rejuvenation Research
4h
MiR-151a-3p Promotes Postmenopausal Osteoporosis by Targeting SOCS5 and Activating JAK2/STAT3 Signaling
Rejuvenation Research, Ahead of Print.
Rejuvenation Research
4h
Blockade of glutathione metabolism in IDH1-mutated glioma
Mutations in genes encoding isocitrate dehydrogenases (IDHs) 1 and 2 are common cancer-related genetic abnormalities. Malignancies with mutated IDHs exhibit similar pathogenesis, metabolic pattern, and resistance signature. However, an effective therapy against IDH1-mutated solid tumor remains unavailable. In the present study, we showed that acquisition of IDH1 mutation results in the disruption of NADP+/NADPH balance and an increased demand for glutathione metabolism. Moreover, the nuclear factor...
Molecular Cancer Therapeutics Online First Articles
4h
Enzalutamide Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 Inhibitors
The second-generation anti-androgen, enzalutamide (ENZ), is approved for castrate-resistant (CR) PC and targets androgen receptor (AR) activity in CRPC. Despite initial clinical activity, acquired resistance to ENZ arises rapidly and most patients develop terminal disease. Previous work has established Stat5 as a potent inducer of PC growth. Here, we investigated the significance of Jak2-Stat5 signaling in resistance of PC to ENZ. The levels of Jak2 and Stat5 mRNA, proteins and activation were evaluated...
Molecular Cancer Therapeutics Online First Articles
4h
Inhibition of autotaxin with GLPG1690 increases the efficacy of radiotherapy and chemotherapy in a mouse model of breast cancer
Autotaxin catalyzes the formation of lysophosphatidic acid, which stimulates tumor growth and metastasis and decreases the effectiveness of cancer therapies. In breast cancer, autotaxin is secreted mainly by breast adipocytes, especially when stimulated by inflammatory cytokines produced by tumors. In this work, we studied the effects of an ATX inhibitor, GLPG1690, which is in Phase 3 clinical trials for idiopathic pulmonary fibrosis, on responses to radiotherapy and chemotherapy in a syngeneic...
Molecular Cancer Therapeutics Online First Articles
4h
Percutaneous transhepatic laser lithotripsy for intrahepatic cholelithiasis: A technical report
Summary Advances in interventional radiology have seen the adaptation of urological endoscopic laser techniques to treat biliary tract calculi. Percutaneous transhepatic biliary laser lithotripsy provides an effective alternative procedure for the management of intrahepatic or conventionally refractory choledocholithiasis which would otherwise require invasive and high‐risk surgical intervention. Several small studies have validated the procedure for management in this subset of patients, with most...
Journal of Medical Imaging and Radiation Oncology
4h
FDA Addresses Breast Cancer in Men [News in Brief]
Agency releases draft guidance outlining strategies to improve drug development for uncommon disease.
Cancer Discovery Online First Articles
4h
Protected Health Info Breaches Compromise Sensitive Data
MONDAY, Sept. 23, 2019 -- Most protected health information (PHI) breaches compromise sensitive demographic and/or financial information, according to a research letter published online Sept. 23 in the Annals of Internal Medicine. John (Xuefeng)...
Drugs.com - Pharma Industry News
4h
Women, Minorities Underrepresented in Cardiology Workforce
MONDAY, Sept. 23, 2019 -- Female physicians remain underrepresented in adult cardiology, according to a study published online Sept. 11 in JAMA Cardiology. Laxmi S. Mehta, M.D., from The Ohio State University in Columbus, and colleagues used data...
Drugs.com - Pharma Industry News
4h
High-Intensity Surveillance of Colorectal Adenomas Modeled
MONDAY, Sept. 23, 2019 -- For patients with colorectal adenomas, high-intensity surveillance could provide modest benefits over low-intensity surveillance, at an acceptable cost, according to a study published online Sept. 24 in the Annals of...
Drugs.com - Pharma Industry News
4h
Guideline Updated for Prevention, Management of Hep C in CKD
MONDAY, Sept. 23, 2019 -- In a synopsis of the 2018 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline, published online Sept. 24 in the Annals of Internal Medicine, updated recommendations are presented for the...
Drugs.com - Pharma Industry News
4h
Connecticut Sees First Death This Year From Mosquito-Borne EEE
MONDAY, Sept. 23, 2019 -- A Connecticut resident has died from eastern equine encephalitis (EEE), the first such death in the state since 2013, health officials report. In addition, another person in the state has contracted the infection, as an...
Drugs.com - Pharma Industry News
4h
Polysomnographic Thresholds of Limited Use in Pediatric OSA
MONDAY, Sept. 23, 2019 -- Polysomnographic resolution of obstructive sleep apnea (OSA) and changes in polysomnographic severity of OSA in children account for a small but significant proportion of changes in symptoms and disease-specific quality of...
Drugs.com - Pharma Industry News
12h
Higher Mortality Seen for Male Breast Cancer Patients
MONDAY, Sept. 23, 2019 -- Male breast cancer patients have higher mortality after cancer diagnosis than female patients, according to a study published online Sept. 19 in JAMA Oncology. Fei Wang, M.D., Ph.D., from the Vanderbilt University Medical...
Drugs.com - Pharma Industry News
12h
Higher Fat Mass May Up Risk for Major Adverse CV Events in T2DM
MONDAY, Sept. 23, 2019 -- In patients with type 2 diabetes, higher fat mass is associated with a higher risk for major adverse cardiovascular events, according to a study published in the Sept. 23 issue of CMAJ, the journal of the Canadian Medical...
Drugs.com - Pharma Industry News
12h
Dapagliflozin Lowers Risk for Worsening Heart Failure
MONDAY, Sept. 23, 2019 -- For patients with heart failure and reduced ejection fraction, dapagliflozin is associated with a lower risk for worsening heart failure or death from cardiovascular causes, regardless of the presence of type 2 diabetes,...
Drugs.com - Pharma Industry News
12h
Emergency Departments Need to Up HIV Testing, Linkage to Care
MONDAY, Sept. 23, 2019 -- HIV testing in South African emergency departments shows a high prevalence and incidence of HIV, as well as significant attrition along the HIV care cascade for HIV-positive individuals, according to a study published...
Drugs.com - Pharma Industry News
12h
Timely Palliative Care After Lung Cancer Diagnosis May Up Survival
MONDAY, Sept. 23, 2019 -- For patients with advanced lung cancer, palliative care is associated with increased survival when it is received 31 to 365 days after cancer diagnosis, according to a study published online Sept. 19 in JAMA...
Drugs.com - Pharma Industry News
12h
ASTRO: NSAIDs May Offer Benefit to Head & Neck Cancer Patients
MONDAY, Sept. 23, 2019 -- Nonsteroidal anti-inflammatory drugs (NSAIDs) are correlated with better overall survival in patients with head and neck squamous cell carcinoma (HNSCC), and there is a nonsignificant benefit for aspirin use in non-small...
Drugs.com - Pharma Industry News
12h
Exercise May Slow Brain Deterioration in Alzheimer Disease
MONDAY, Sept. 23, 2019 -- Exercising may delay brain deterioration in people at high risk for Alzheimer disease, according to a proof-of-concept study published Sept. 17 in the Journal of Alzheimer's Disease. Takashi Tarumi, Ph.D., from Texas Health...
Drugs.com - Pharma Industry News
12h
Rate of Vaping Has Doubled Since 2017 Among U.S. Adolescents
MONDAY, Sept. 23, 2019 -- Vaping is increasing among adolescents, with significant increases seen from 2018 to 2019, according to a research letter published online Sept. 18 in the New England Journal of Medicine. Richard Miech, Ph.D., from the...
Drugs.com - Pharma Industry News
12h
More Aggressive Tx Needed for Familial Hypercholesterolemia
MONDAY, Sept. 23, 2019 -- Even with care in specialty clinics, low-density lipoprotein cholesterol (LDL-C) persists above target levels in more than half of patients with familial hypercholesterolemia (FH), according to a study published in the...
Drugs.com - Pharma Industry News
12h
Colicin U from Shigella boydii forms voltage-dependent pores [Article]
Colicin U is a protein produced by the bacterium Shigella boydii (serovars 1 and 8). It exerts antibacterial activity against strains of the enterobacterial genera Shigella and Escherichia. Here we report that colicin U forms voltage-dependent pores in planar lipid membranes; its single-pore conductance was found to be about 22 pS in 1M KCl, at pH 6 under 80 mV in asolectin bilayers. In agreement with the high degree of homology between their C-terminal domains, colicin U shares some pore characteristics...
JB Accepts: Articles Published Ahead of Print
4h
Characterization of the chromosome dimer resolution site in Caulobacter crescentus [Article]
Chromosome dimers occur in bacterial cells as a result of the recombinational repair of DNA. In most bacteria, chromosome dimers are resolved by XerCD site specific recombination at the dif (deletion induced filamentation) site located in the terminus region of the chromosome. Caulobacter crescentus, a gram-negative oligotrophic bacterium, also possesses Xer recombinases called CcXerC and CcXerD, which have been shown to interact with the Escherichia coli dif site in vitro. Previous studies on Caulobacter...
JB Accepts: Articles Published Ahead of Print
4h
A Universal Stress Protein that Controls Bacterial Stress Survival in Micrococcus luteus [Article]
Bacteria have remarkable mechanisms to survive severe external stresses and one of the most enigmatic is the non-replicative persistent (NRP) state. Practically, NRP bacteria are difficult to treat, so inhibiting proteins underlying this survival state may render such bacteria more susceptible to external stresses including antibiotics. Unfortunately, we know little about the proteins and mechanisms conferring survival through NRP. Here, we report a universal stress protein (Usps) is a primary regulator...
JB Accepts: Articles Published Ahead of Print
4h
'It takes a village: mechanisms underlying antimicrobial recalcitrance of polymicrobial biofilms [Minireviews]
Chronic infections are frequently caused by polymicrobial biofilms. Importantly, these infections are often difficult to treat effectively in part due to the recalcitrance of biofilms to antimicrobial therapy. Emerging evidence suggests that polymicrobial interactions can lead to dramatic and unexpected changes in the ability of antibiotics to eradicate biofilms, and often result in decreased antimicrobial efficacy in vitro. In this review, we discuss the influence of polymicrobial interactions on...
JB Accepts: Articles Published Ahead of Print
4h
Regulation of cell division in bacteria by monitoring genome integrity and DNA replication status [Minireviews]
All organisms regulate cell cycle progression by coordinating cell division with DNA replication status. In eukaryotes, DNA damage or problems with replication fork progression induce the DNA damage response (DDR) causing cyclin-dependent kinases to remain active preventing further cell cycle progression until replication and repair are complete. In bacteria, cell division is coordinated with chromosome segregation preventing cell division ring formation over the nucleoid in a process termed nucleoid...
JB Accepts: Articles Published Ahead of Print
4h
Specific driving of the suicide <i>E</i> gene by the CEA promoter enhances the effects of paclitaxel in lung cancer
Cancer Gene Therapy, Published online: 24 September 2019; doi:10.1038/s41417-019-0137-3Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer
Cancer Gene Therapy - Issue - nature.com science feeds
4h
Specific driving of the suicide <i>E</i> gene by the CEA promoter enhances the effects of paclitaxel in lung cancer
Cancer Gene Therapy - Issue - nature.com science feeds
7h

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου